Filing Details
- Accession Number:
- 0001760460-23-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-10-16 20:51:41
- Reporting Period:
- 2023-10-13
- Accepted Time:
- 2023-10-16 20:51:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1600132 | Bellerophon Therapeutics Inc. | BLPH | Pharmaceutical Preparations (2834) | 473116175 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1658437 | Puissance Capital Management Lp | 45 E 85Th St 5A New York NY 10028 | No | No | Yes | No | |
1694061 | T Theodore Wang | C/O Puissance Capital Management Lp 950 Third Avenue, 25Th Floor New York NY 10022 | No | No | Yes | No | |
1695347 | Puissance Capital Fund (Gp) Llc | 950 Third Avenue 25Th Floor New York NY 10022 | No | No | Yes | No | |
1760460 | Vi Fund Opportunities Science Life Puissance | 950 Third Avenue Fl 25 New York NY 10022 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-10-13 | 1,076,841 | $0.10 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |